4-butyrolactone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Aryandono, T; Chao, TY; Deng, L; Fong, IH; Haryana, SM; Huang, CC; Huang, WC; Lin, CC; Liu, HW; Ong, JR; Satriyo, PB; Su, CM; Tzeng, YM; Yeh, CT | 1 |
Chen, X; De, S; Rotenberg, SA; Tsimounis, A | 1 |
2 other study(ies) available for 4-butyrolactone and ER-Negative PR-Negative HER2-Negative Breast Cancer
Article | Year |
---|---|
4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclohexanones; DNA Damage; DNA Repair; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred NOD; Mice, SCID; Signal Transduction; Triple Negative Breast Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |
Phosphorylation of α-tubulin by protein kinase C stimulates microtubule dynamics in human breast cells.
Topics: 4-Butyrolactone; Breast; Cell Line, Transformed; Cell Movement; Cell Survival; Enzyme Activation; Female; Fluorescent Antibody Technique; Green Fluorescent Proteins; Humans; Microtubule-Associated Proteins; Microtubules; Models, Biological; Mutant Proteins; Neoplasm Metastasis; Phosphorylation; Phosphoserine; Protein Kinase C; rac1 GTP-Binding Protein; Recombinant Fusion Proteins; Triple Negative Breast Neoplasms; Tubulin; Valerates | 2014 |